Neurocrine Bioscience buy Piper Sandler
Start price
23.12.24
/
50%
€130.60
Target price
23.12.25
€153.97
Performance (%)
-6.36%
End price
24.12.25
€122.30
Summary
This prediction ended on 24.12.25 with a price of €122.30. With a performance of -6.36%, the BUY prediction for Neurocrine Bioscience by Piper_Sandler closed slightly in the red. Piper_Sandler has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.453% | -2.453% | 30.601% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $160.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€136.35
06.05.26
06.05.26
5.15%
15.04.26
15.04.26
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
-5.52%
15.04.26
15.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
-3.38%
15.04.26
15.04.26